Download our new White Paper now: Environmental Beneﬁts of NorthStar Medical Radioisotopes’ Non–Uranium-Based Production Method for Molybdenum-99/Technetium-99m
Our innovative products and technologies define a new era in current and future diagnostic and therapeutic radiopharmaceuticals.
We lead the way in producing stable, reliable, domestically-sourced, environmentally-friendly radioisotope supply to meet critical patient healthcare needs and advance clinical research.
We are a recognized, emerging global leader with a proven track record and strong vision for the future of radiopharmaceuticals. Our innovation-driven technology is transforming the landscape for medical radioisotope production and distribution around the world.
NorthStar Medical Radioisotopes Expands Business Platform with New, Patient-focused, Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) Services UnitRead More >
Radiopharm Theranostics signs agreement with NorthStar Medical Radioisotopes for the supply of non-carrier added (n.c.a.) Actinium-225Read More >
Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes’ Dedicated Actinium-225 Production FacilityRead More >